Loading...

Veradermics, Incorporated

MANE•NYSE
Healthcare
Biotechnology
$100.10
$32.26(47.55%)
U.S. Market opens in 10h 23m

Veradermics, Incorporated (MANE) Stock Overview

Explore Veradermics, Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.7B
P/E Ratio-730.30
EPS (TTM)$-2.37
ROE-0.76%
Fundamental Analysis

AI Price Forecasts

1 Month$48.91
3 Months$42.38
1 Year TargetN/A

MANE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Veradermics, Incorporated (MANE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.82, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -730.30 and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
47.79%
5-Day Change
33.59%
1-Month Change
53.00%
3-Month Change
165.59%
6-Month Change
165.59%
Year-to-Date (YTD) Change
165.59%
1-Year Change
165.59%
3-Year Change
165.59%
5-Year Change
165.59%
All-Time (Max) Change
165.59%

Contact Information

https://www.veradermics.com
(228) 372-3376
470 James Street, New Haven, CT, 06513

Company Facts

21 Employees
IPO DateFeb 4, 2026
CountryUS
Actively Trading

Frequently Asked Questions